UBE2O and pancreatic neoplasm: CircPDK1 also serves as a skeleton to strengthen the contact of ubiquitin-conjugating enzyme E2O (UBE2O) with bridging integrator 1 (BIN1), causing UBE2O-mediated degradation of BIN1 and accelerating the advancement of pancreatic cancer [34].